Literature DB >> 15168156

Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis.

Bahar Ulubaş1, Günşah Sahin, Caner Ozer, Ozlem Aydin, Eylem Ozgür, Demir Apaydin.   

Abstract

Pulmonary toxicity and blood dyscrasias are rare side effects of sulfasalazine. Pulmonary pathology is variable, the most common being eosinophilic pneumonia with peripheral eosinophilia, and interstitial inflammation with or without fibrosis. We here present the case of a 68-year-old female patient treated for 6 months with sulfasalazine for rheumatoid arthritis. On laboratory examination, eosinophil count was 97 x 10(3) mm(3). Thorocoscopic biopsy was performed. Histopathologic diagnosis was bronchiolitis obliterans organizing pneumonia (BOOP). This is the first case in the literature to present with sulfasalazine-induced BOOP in a patient with seronegative RA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15168156     DOI: 10.1007/s10067-003-0848-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  4 in total

Review 1.  Sulphasalazine and lung toxicity.

Authors:  S D Parry; C Barbatzas; E T Peel; J R Barton
Journal:  Eur Respir J       Date:  2002-04       Impact factor: 16.671

2.  [DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) syndrome after sulfasalazine and carmazepine: report of two cases].

Authors:  V Queyrel; B Catteau; U Michon-Pasturel; A L Fauchais; V Delcey; D Launay; L Legout; E Hachulla; P Y Hatron; B Devulder
Journal:  Rev Med Interne       Date:  2001-06       Impact factor: 0.728

3.  Migratory pulmonary infiltrates in a patient with rheumatoid arthritis.

Authors:  S Mehandru; R L Smith; G S Sidhu; N Cassai; C P Aranda
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

4.  Pulmonary infiltrates and skin pigmentation associated with sulfasalazine.

Authors:  E C Gabazza; O Taguchi; T Yamakami; M Machishi; H Ibata; S Suzuki; K Matsumoto; T Kitagawa; J Yamamoto
Journal:  Am J Gastroenterol       Date:  1992-11       Impact factor: 10.864

  4 in total
  7 in total

1.  Sulfasalazine-Induced Interstitial Fibrosis.

Authors:  Bugra Kerget; Omer Araz; Elif Yilmazel Ucar; Ozkan Aydin; Metin Akgun; Leyla Saglam
Journal:  Eurasian J Med       Date:  2018-10

2.  Cryptogenic organizing pneumonia (COP), as presentation of rheumatoid arthritis.

Authors:  Javier Alberto Cavallasca; Mariana Caubet; Claudia Andrea Helling; Guillermo Alberto Tate
Journal:  Rheumatol Int       Date:  2008-05-24       Impact factor: 2.631

Review 3.  Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review.

Authors:  Antonella Laria; Alfredo Maria Lurati; Gaetano Zizzo; Eleonora Zaccara; Daniela Mazzocchi; Katia Angela Re; Mariagrazia Marrazza; Paola Faggioli; Antonino Mazzone
Journal:  Front Med (Lausanne)       Date:  2022-05-13

4.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Sebastian Majewski; Wojciech Piotrowski
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

Review 5.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

Review 6.  Thoracic Manifestations of Rheumatoid Arthritis.

Authors:  Anthony J Esposito; Sarah G Chu; Rachna Madan; Tracy J Doyle; Paul F Dellaripa
Journal:  Clin Chest Med       Date:  2019-07-06       Impact factor: 4.967

Review 7.  Organizing Pneumonia in Rheumatoid Arthritis Patients: A Case-Based Review.

Authors:  Shunsuke Mori; Yukinori Koga; Mineharu Sugimoto
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.